These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22477643)

  • 1. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.
    Lu W; Zhang C; Yi Z; Li Z; Wu Z; Fang Y
    J Mol Neurosci; 2012 Jul; 47(3):505-10. PubMed ID: 22477643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients.
    Chung S; Chung HY; Jung J; Chang JK; Hong JP
    Compr Psychiatry; 2010; 51(4):367-72. PubMed ID: 20579509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
    Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
    Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of Val66Met polymorphism of brain-derived neurotrophic factor gene with cognitive impairment and clinical symptoms in first episode schizophrenia].
    Zhang C; Gu X; Wang Q; Li M; Deng W; Guo W; Zhao L; Ma X; Li T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):592-596. PubMed ID: 28777866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction effect between BDNF val66met polymorphism and obesity on executive functions and frontal structure.
    Marqués-Iturria I; Garolera M; Pueyo R; Segura B; Hernan I; García-García I; Sánchez-Garre C; Vernet-Vernet M; Sender-Palacios MJ; Narberhaus A; Ariza M; Junqué C; Jurado MÁ
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):245-53. PubMed ID: 24619555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
    Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
    Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia.
    Ho BC; Andreasen NC; Dawson JD; Wassink TH
    Am J Psychiatry; 2007 Dec; 164(12):1890-9. PubMed ID: 18056245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
    Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
    Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BDNF Gene Val66Met Polymorphism with Suicide Attempts, Focused Attention and Response Inhibition in Patients with Schizophrenia.
    Bolat Kaya Ö; Kaya H; Civan Kahve A; Enez Darçin A; Yalçin Çavuş RS; Dilbaz N
    Noro Psikiyatr Ars; 2022; 59(2):91-97. PubMed ID: 35685050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
    Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
    Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
    Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
    Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
    Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
    Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
    Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.
    Xu MQ; St Clair D; Ott J; Feng GY; He L
    Schizophr Res; 2007 Mar; 91(1-3):6-13. PubMed ID: 17289348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.